• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

BD enrolls first patients in arteriovenous endovascular fistula post-market trial

May 12, 2021 By Danielle Kirsh

bd-wavelinQBD (NYSE: BDX) recently announced that it has begun enrollment for its post-market surveillance study of its WavelinQ arteriovenous endovascular fistula device.

The Connect-AV trial is a prospective, single-arm, open-label study that will follow WavelinQ EndoAVF system patients for 24 months. Its dual primary effectiveness endpoints are the percentage of subjects dialyzing with successful 2-needle cannulation for at least 75% of dialysis sessions over a 28-day period, and subjects who are maintaining primary patency at six months. The primary safety endpoint is freedom from the device and procedure-related serious adverse events for 30 days.

“For more than 50 years, medicine has looked for a next-generation hemodialysis access procedure for patients with ESKD that can truly change the treatment paradigm,” Brandon Repko, medical director of nuclear imaging and therapeutic services at Butler Memorial Hospital in Butler, Penn., said in a news release. “The Connect-AV trial is the next step in proving WavelinQ EndoAVF System’s role in 21st century AV fistula creation. My colleagues and I are thrilled to be a part of that patient care evolution.”

WavelinQ EndoAVF is indicated to create an arteriovenous fistula using concomitant ulnar artery and ulnar vein in hemodialysis patients with minimum artery and vein diameters of 2.0 mm at the fistula creation site.

The Connect-AV study is BD’s second post-market study of the device. The other study, Wave-Global, is a prospective, single-arm, open-label study that will follow patients treated with the WavelinQ system for 24 months.

“Physicians already have real-world experience using the WavelinQ EndoAVF System to create AV fistulas that make life-preserving hemodialysis possible,” Panagiotis Kitrou, assistant professor of interventional radiology at Patras University Hospital in Greece, said. “Both of these studies will provide important long-term data on the safety and effectiveness of WavelinQ EndoAVF System to help make informed decisions about patient care.”

Filed Under: Catheters Tagged With: BD

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS